Pharmaceuticals, Biotechnology and Life Sciences
VANCOUVER, British Columbia–(BUSINESS WIRE)–Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing multifunctional therapeutics, today announced the appointment of Kathryn…
TriPharm services creates Pharmaceutical manufacturing center to address Shortage of qualified parenteral manufacturing options in the U.S.
Amphivena is set to move on with AMV564 in a Multi-Center Dose Finding Phase 1 Clinical Study in Patients with…
Enzyvant appoints former COO of Compass and Horizon Discovery as Chief Operating Officer, as the company nears first potential drug…
BOSTON–(BUSINESS WIRE)–Pyxis Oncology, an immuno-oncology company focused on developing a new family of antibody-based immunotherapies derived from novel insights into…
Credence got a grant from the Bill & Melinda Gates Foundation with which it plans funding will support development of…
Sun pharma has launched the first and only FDA-approved sprinkle formulation of delayed-release duloxetine capsules, which is, as the company…
Aura Biosciences said in a presentation at American Academy od Ophtalmology that its lead product candidate light-activated AU-011 has the potential to be the first FDA approved therapy for the primary treatment of choroidal melanoma.
MIAMI & JERSEY CITY, N.J.–(BUSINESS WIRE)–Noven Pharmaceuticals, Inc., a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., Inc., today announced the U.S.…
FARMINGTON, Conn.–(BUSINESS WIRE)–Azitra Inc., a clinical-stage medical dermatology company addressing serious skin conditions by harnessing the microbiome, today announced that…